Analyst picks & changes

Creative BioMolecules Inc.

Robert Fine of Nomura Equity Research initiated coverage of Creative BioMolecules Inc. with a "buy." He said CBMI shares have

Read the full 220 word article

How to gain access

Continue reading with a
two-week free trial.